FDA одобрило первый ингибитор фактора свертывания XIа для профилактики повторного инсульта
- Words
- 11
- Chars
- 90
- AI summary
- Yes
Full story
The FDA has approved the first inhibitor of coagulation factor XIa, a drug class targeted at preventing recurrent strokes. The approval covers use in prophylaxis against a repeat stroke. The source did not name the product or its manufacturer.
FDA одобрило первый ингибитор фактора свертывания XIа для профилактики повторного инсульта
Open article